Bumper Offer - Urjas oil Just @ Rs. 1
Clarigard 500 Tablet is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Sinusitis, Tonsillitis, Bronchitis. Clarigard 500 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Clarigard 500 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Clarigard 500 Tablet can also lead to other problems, which have been listed below. Such side effects of Clarigard 500 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Clarigard 500 Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. In addition, Clarigard 500 Tablet's effects on the liver, heart and kidney are discussed below in the Clarigard 500 Tablet related warnings section.
Other conditions have been mentioned below in the Clarigard 500 Tablet contraindications section.
Drug interactions for Clarigard 500 Tablet have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Clarigard 500 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Clarigard 500 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Clarigard 500 Tablet is used -
Mild
Is the use of Clarigard 500 Tablet safe for pregnant women?
Clarigard should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Clarigard 500 Tablet safe during breastfeeding?
Side effects of Clarigard for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Clarigard 500 Tablet on the Kidneys?
Clarigard has very mild side effects on the kidneys.
What is the effect of Clarigard 500 Tablet on the Liver?
Side effects of Clarigard rarely affect the liver.
What is the effect of Clarigard 500 Tablet on the Heart?
Using Clarigard does not have any harmful effects on the heart.
Clarigard 500 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Clarigard 500 Tablet unless your doctor advises you to do so -
Is this Clarigard 500 Tablet habit forming or addictive?
No, there is no any evidence that Clarigard 500 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Clarigard 500 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Clarigard 500 Tablet only as per medical advice.
Is it able to treat mental disorders?
Clarigard 500 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Clarigard 500 Tablet
Taking Clarigard 500 Tablet with food is safe.
Interaction between Alcohol and Clarigard 500 Tablet
Due to lack of research, there is no information about the side effects of taking Clarigard 500 Tablet with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Biaxin® Filmtab® (clarithromycin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 754-755
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 326-328
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Biaxin® Filmtab® (clarithromycin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 754-755
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 326-328
